AusMedtech 2018 seeks to present a suite of topics relevant to the global medical technology industry. You can download the full program to date by clicking on the button below.
- Nurturing the pipeline: Key issues for big medtech
- Clinical trials
- Design led concept validation/feasibility
- Preclinical work, what resources are available and how do you use them
- Sources of innovation
- Attracting talent and building your team
AusMedtech 2018 plenary to present inventor of world-first low cost dialysis system
Five million people in the world need dialysis right now for terminal kidney failure, but only 2.5 million have access to it, mostly due to cost – the rest will die an unpleasant death. Vincent Garvey, Chairman and Chief Executive of Ellen Medical Devices and winner of the global Affordable Dialysis Prize in March 2016 will present on his invention: the world's first affordable dialysis system which will help save millions of lives.
Clinician led-innovation, how do we help them get products to market?
Australia has many internationally renowned clinical experts that work in a sophisticated clinical environment. Our healthcare system has high standards of care and widespread use of high-end medical devices and diagnostics. Our clinicians are at the front line, using these devices daily and identifying opportunities for improvement and new solutions. This fireside chat chaired by Dr Judy Halliday, Director, Industry Development, TechInSA will not only highlight some successful clinician-led innovation case studies but will also delve into some of limitations that exist and explore opportunities to support entrepreneurial clinicians in Australia.
Attracting talent and building your team
Human capital is often referred to as a company’s greatest asset. However, engineering your medtech talent is not always straightforward. This panel will explore skills shortages in medtech in Australia, embracing flexible work arrangements, using incentives to get the best people on your team, diversity in the workforce, and a case study from someone who has built an effective team in the medtech space.
Digital health in the spotlight. Keynote speaker: Anand Iyer, Co-Founder & Chief Strategy Officer, WellDoc
Anand is a respected global digital health leader—best known for his insights into and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®, the first FDA-cleared mobile prescription therapy, for adults with type 2 diabetes. In 2013, Anand was named “Maryland Healthcare Innovator of the Year” in the field of mobile health
A significant trend in healthcare innovation is the combining of different medical technologies to deliver more effective products, drive product enhancements or to create completely new product types. The convergence of technologies such as AI, robotics, data analytics, as well as new advances in drug delivery and surface modification technologies with traditional devices has, and will continue to, disrupt healthcare as we know it. Our panel will examine this fast moving space and explore the implications of technology convergence and why medical device companies cannot afford to ignore it.
· Chair: Rachel Hooke, Partner, FB Rice
· Prof Anton van den Hengel, School of Computer Science, The University of Adelaide
· Stefan Mauger, Principal Research Engineer, Cochlear
· Garth Sutherland, Founder, Adherium Limited
· Dean Freestone, Co-Founder and Managing Director, Seer Medical
· Ann Damien, New Technology Associate, Cook Medical